TrialClinical cancer research : an official journal of the American Association for Cancer Research2008

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.

Annick Desjardins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.